Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urtiplex is a proprietary Ayurvedic formulation developed by Charak Pharma, available in both oral capsule and topical lotion forms. It is designed to provide natural relief from skin allergic conditions, including urticaria (hives), pruritus (itching), allergic dermatitis, atopic eczema, and prickly heat. The oral capsules contain a synergistic blend of traditional blood-purifying, anti-allergic, and anti-inflammatory herbs such as Manjistha (*Rubia cordifolia*), Haridra (*Curcuma longa*), Amalaki (*Emblica officinalis*), Usheer (*Andropogon muricatus*), and Daruharidra (*Berberis aristata*). The topical lotion is formulated with soothing ingredients like Aloe vera (*Kumari*), Kokum butter, and Menthol to deliver a cooling effect, reduce skin inflammation, and alleviate burning sensations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Urtiplex.